BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 22956261)

  • 1. Aberrant microRNA expression and its implications in the pathogenesis of leukemias.
    Babashah S; Sadeghizadeh M; Tavirani MR; Farivar S; Soleimani M
    Cell Oncol (Dordr); 2012 Oct; 35(5):317-34. PubMed ID: 22956261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA and leukemia: tiny molecule, great function.
    Zhao H; Wang D; Du W; Gu D; Yang R
    Crit Rev Oncol Hematol; 2010 Jun; 74(3):149-55. PubMed ID: 19520590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic regulation of miRNA genes in acute leukemia.
    Agirre X; Martínez-Climent JÁ; Odero MD; Prósper F
    Leukemia; 2012 Mar; 26(3):395-403. PubMed ID: 22143672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. microRNAs and their potential target genes in leukemia pathogenesis.
    Dong C; Ji M; Ji C
    Cancer Biol Ther; 2009 Feb; 8(3):200-5. PubMed ID: 19106636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA: Defining a new niche in Leukemia.
    Fernandes Q
    Blood Rev; 2017 May; 31(3):129-138. PubMed ID: 28087197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA: an important regulator in acute myeloid leukemia.
    Wang X; Chen H; Bai J; He A
    Cell Biol Int; 2017 Sep; 41(9):936-945. PubMed ID: 28370893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miRNAs in chronic myeloid leukemia: small molecules, essential function.
    Litwińska Z; Machaliński B
    Leuk Lymphoma; 2017 Jun; 58(6):1297-1305. PubMed ID: 27736267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA profiling can classify acute leukemias of ambiguous lineage as either acute myeloid leukemia or acute lymphoid leukemia.
    de Leeuw DC; van den Ancker W; Denkers F; de Menezes RX; Westers TM; Ossenkoppele GJ; van de Loosdrecht AA; Smit L
    Clin Cancer Res; 2013 Apr; 19(8):2187-96. PubMed ID: 23444217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNAs as New Biomarkers for Diagnosis and Prognosis, and as Potential Therapeutic Targets in Acute Myeloid Leukemia.
    Trino S; Lamorte D; Caivano A; Laurenzana I; Tagliaferri D; Falco G; Del Vecchio L; Musto P; De Luca L
    Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29401684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNAs Associated With a Good Prognosis of Acute Myeloid Leukemia and Their Effect on Macrophage Polarization.
    Neaga A; Bagacean C; Tempescul A; Jimbu L; Mesaros O; Blag C; Tomuleasa C; Bocsan C; Gaman M; Zdrenghea M
    Front Immunol; 2020; 11():582915. PubMed ID: 33519805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New insight into the role of miRNAs in leukemia.
    Zhang H; Chen Y
    Sci China C Life Sci; 2009 Mar; 52(3):224-31. PubMed ID: 19294347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prognostic and functional role of microRNAs in acute myeloid leukemia.
    Marcucci G; Mrózek K; Radmacher MD; Garzon R; Bloomfield CD
    Blood; 2011 Jan; 117(4):1121-9. PubMed ID: 21045193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA expression in acute myeloid leukemia.
    Marcucci G; Radmacher MD; Mrózek K; Bloomfield CD
    Curr Hematol Malig Rep; 2009 Apr; 4(2):83-8. PubMed ID: 20425419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MiR-495 is a tumor-suppressor microRNA down-regulated in MLL-rearranged leukemia.
    Jiang X; Huang H; Li Z; He C; Li Y; Chen P; Gurbuxani S; Arnovitz S; Hong GM; Price C; Ren H; Kunjamma RB; Neilly MB; Salat J; Wunderlich M; Slany RK; Zhang Y; Larson RA; Le Beau MM; Mulloy JC; Rowley JD; Chen J
    Proc Natl Acad Sci U S A; 2012 Nov; 109(47):19397-402. PubMed ID: 23132946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of miRNomes in acute and chronic myeloid leukemia cell lines.
    Xiong Q; Yang Y; Wang H; Li J; Wang S; Li Y; Yang Y; Cai K; Ruan X; Yan J; Hu S; Fang X
    Genomics Proteomics Bioinformatics; 2014 Apr; 12(2):79-91. PubMed ID: 24755403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical significance of microRNAs in chronic and acute human leukemia.
    Yeh CH; Moles R; Nicot C
    Mol Cancer; 2016 May; 15(1):37. PubMed ID: 27179712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA expression signatures accurately discriminate acute lymphoblastic leukemia from acute myeloid leukemia.
    Mi S; Lu J; Sun M; Li Z; Zhang H; Neilly MB; Wang Y; Qian Z; Jin J; Zhang Y; Bohlander SK; Le Beau MM; Larson RA; Golub TR; Rowley JD; Chen J
    Proc Natl Acad Sci U S A; 2007 Dec; 104(50):19971-6. PubMed ID: 18056805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression pattern of key microRNAs in patients with newly diagnosed chronic myeloid leukemia in chronic phase.
    Fallah P; Amirizadeh N; Poopak B; Toogeh G; Arefian E; Kohram F; Hosseini Rad SM; Kohram M; Teimori Naghadeh H; Soleimani M
    Int J Lab Hematol; 2015 Aug; 37(4):560-8. PubMed ID: 25833191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNAs expression signatures are associated with lineage and survival in acute leukemias.
    Wang Y; Li Z; He C; Wang D; Yuan X; Chen J; Jin J
    Blood Cells Mol Dis; 2010 Mar; 44(3):191-7. PubMed ID: 20110180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miRNAs in acute myeloid leukemia.
    Liao Q; Wang B; Li X; Jiang G
    Oncotarget; 2017 Jan; 8(2):3666-3682. PubMed ID: 27705921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.